Live feed06:45:00·1400dPRReleasevia QuantisnowMerck Receives Fast Track Designation from the U.S. FDA for MK-2060, an Investigational Anticoagulant TherapyByQuantisnow·Wall Street's wire, on your screen.MRK· Merck & Company Inc.Health Care
